Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FFAR1 | O14842 | 1/20 | 0.41 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.38 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.35 |
| ▸ | CA1 | P00915 | 1/20 | 0.32 |
| ▸ | CA2 | P00918 | 1/20 | 0.32 |
| ▸ | CA4 | P22748 | 1/20 | 0.32 |
| ▸ | CA6 | P23280 | 1/20 | 0.32 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.32 |
| ▸ | GAA | P10253 | 1/20 | 0.31 |
| ▸ | TAAR1 | Q96RJ0 | 1/20 | 0.31 |
| ▸ | APP | P05067 | 1/20 | 0.30 |
| ▸ | PLCG1 | P19174 | 1/20 | 0.30 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.30 |
| ▸ | MEN1 | O00255 | 1/20 | 0.30 |
| ▸ | NPC1 | O15118 | 1/20 | 0.30 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.30 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.30 |
| ▸ | MAPT | P10636 | 1/20 | 0.30 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.30 |
| ▸ | HPGD | P15428 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2466535 | 0.88 | FFAR1 (0.47) | FFAR1ALDH1A1MAPK1CA1CA2 | |
| SCHEMBL30468202 | 0.88 | FFAR1 (0.47) | FFAR1ALDH1A1MAPK1CA1CA2 | |
| SCHEMBL28016124 | 0.83 | FFAR1 (0.41) | FFAR1ALDH1A1MAPK1CA1CA2 | |
| SCHEMBL28401249 | 0.81 | FFAR1 (0.40) | FFAR1ALDH1A1MAPK1CA1CA2 | |
| SCHEMBL3282977 | 0.79 | FFAR1 (0.42) | FFAR1ALDH1A1MAPK1CA1CA2 | |
| SCHEMBL2089353 | 0.79 | ALDH1A1 (0.40) | FFAR1ALDH1A1MAPK1CA1CA2 | |
| SCHEMBL12408477 | 0.79 | FFAR1 (0.59) | FFAR1ALDH1A1CA1CA2APP | |
| SCHEMBL8780975 | 0.79 | FFAR1 (0.42) | FFAR1ALDH1A1MAPK1CA1CA2 | |
| SCHEMBL1920588 | 0.77 | FFAR1 (0.57) | FFAR1ALDH1A1MAPK1CA1CA2 | |
| SCHEMBL29843195 | 0.77 | FFAR1 (0.57) | FFAR1ALDH1A1MAPK1CA1CA2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8044218-B2 | Chalcogen-containing fused polycyclic organic material and method for producing same | JAPAN SCIENCE AND TECHNOLOGY AGENCY (JP) | 2011-10-25 | — | — | US | disclosed |
| EP-1700860-B1 | POLYCYCLIC FUSED RING TYPE PI-CONJUGATED ORGANIC MATERIALS, INTERMEDIATE THEREFOR, PROCESS FOR PRODUCING POLYCYCLIC FUSED RING TYPE PI-CONJUGATED ORGANIC MATERIALS, AND PROCESS FOR PRODUCING INTERMEDIATE FOR POLYCYCLIC FUSED RING TYPE PI-CONJUGATED ORGANIC MATERIALS | JAPAN SCIENCE & TECH AGENCY (JP) | 2011-07-27 | — | — | EP | disclosed |
| US-7973190-B2 | Polycyclic fused ring type π-conjugated organic material, intermediate therefor, process for producing polycyclic fused ring type π-conjugated organic material, and process for producing intermediate of polycyclic fused ring type π-conjugated organic material | JAPAN SCIENCE AND TECHNOLOGY AGENCY (JP) | 2011-07-05 | — | — | US | disclosed |
| US-7973190-B2 | Polycyclic fused ring type π-conjugated organic material, intermediate therefor, process for producing polycyclic fused ring type π-conjugated organic material, and process for producing intermediate of polycyclic fused ring type π-conjugated organic material | JAPAN SCIENCE AND TECHNOLOGY AGENCY (JP) | 2011-07-05 | — | — | US | disclosed |
| US-20090143605-A1 | POLYCYCLIC FUSED RING TYPE PI-CONJUGATED ORGANIC MATERIAL, INTERMEDIATE THEREFOR, PROCESS FOR PRODUCING POLYCYCLIC FUSED RING TYPE PI-CONJUGATED ORGANIC MATERIAL, AND PROCESS FOR PRODUCING INTERMEDIATE OF POLYCYCLIC FUSED RING TYPE PI-CONJUGATED ORGANIC MATERIAL | JAPAN SCIENCE AND TECHNOLOGY AGENCY (JP) | 2009-06-04 | — | — | US | disclosed |
| US-20090143605-A1 | POLYCYCLIC FUSED RING TYPE PI-CONJUGATED ORGANIC MATERIAL, INTERMEDIATE THEREFOR, PROCESS FOR PRODUCING POLYCYCLIC FUSED RING TYPE PI-CONJUGATED ORGANIC MATERIAL, AND PROCESS FOR PRODUCING INTERMEDIATE OF POLYCYCLIC FUSED RING TYPE PI-CONJUGATED ORGANIC MATERIAL | JAPAN SCIENCE AND TECHNOLOGY AGENCY (JP) | 2009-06-04 | — | — | US | disclosed |
| US-20070117973-A1 | Chalcogen-containing fused polycyclic organic material and method for producing same | JAPAN SCIENCE AND TECHNOLOGY AGENCY (JP) | 2007-05-24 | — | — | US | disclosed |
| EP-1700860-A1 | POLYCYCLIC FUSED RING TYPE PI-CONJUGATED ORGANIC MATERIALS, INTERMEDIATE THEREFOR, PROCESS FOR PRODUCING POLYCYCLIC FUSED RING TYPE PI-CONJUGATED ORGANIC MATERIALS, AND PROCESS FOR PRODUCING INTERMEDIATE FOR POLYCYCLIC FUSED RING TYPE PI-CONJUGATED ORGANIC MATERIALS | Japan Science and Technology Agency (JP) | 2006-09-13 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090143605-A1 | POLYCYCLIC FUSED RING TYPE PI-CONJUGATED ORGANIC MATERIAL, INTERMEDIATE THEREFOR, PROCESS FOR PRODUCING POLYCYCLIC FUSED RING TYPE PI-CONJUGATED ORGANIC MATERIAL, AND PROCESS FOR PRODUCING INTERMEDIATE OF POLYCYCLIC FUSED RING TYPE PI-CONJUGATED ORGANIC MATERIAL | THEM6, RICTOR, FARSB | FFAR1 3114/4885ALDH1A1 3932/4885MAPK1 3046/4885 |
| US-20070117973-A1 | Chalcogen-containing fused polycyclic organic material and method for producing same | SLC43A1, OCIAD2, SLC22A8 | FFAR1 4472/4885ALDH1A1 4207/4885MAPK1 3271/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.